£111.63

Springer Tumors of the Central Nervous System, Volume 5: Astrocytomas, Hemangioblastomas, and Gangliogliomas

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 90 days • 90 data points

Historical
Generating forecast...
£113.93 £111.25 £111.83 £112.42 £113.00 £113.59 £114.17 11 February 2026 05 March 2026 27 March 2026 18 April 2026 11 May 2026

Price Distribution

Price distribution over 90 days • 3 price levels

Days at Price
Current Price
16 days · current 44 days 30 days 0 11 22 33 44 £112 £113 £114 Days at Price

Price Analysis

Most common price: £113 (44 days, 48.9%)

Price range: £112 - £114

Price levels: 3 different prices over 90 days

Description

Product Description This comprehensive source on the families of tumors of the title is the fifth volume in a series and covers every clinical aspect, from diagnosis (including imaging techniques) to therapy (including nanotechnology-based), biomarkers, and molecular genetics. Review From the reviews: “This book covers the molecular, medical, radiosurgical, and surgical management of intracranial tumors including astrocytomas, hemangioblastomas, and gangliogliomas. The purpose is to address the most recent advances in the management of these tumors. Neurologists, neurosurgeons, and radiologists are the intended audience. … This is an excellent contribution to neurosurgery and should be part of most academic neurosurgery and neurology libraries.” (Celso Agner, Doody’s Review Service, April, 2012) From the Back Cover The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented.  The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
27 November 2013
Listed Since
17 January 2014

Barcode

No barcode data available

Similar Products You Might Like

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
64% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£107.32 13 Jan 2026
Advances in Biology and Treatment of Glioblastoma (Current Cancer Research)
63% match

Advances in Biology and Treatment of Glioblastoma (Current Cancer Research)

Springer

£110.81 10 Mar 2026
Springer - Advances in Biology and Treatment of Glioblastoma
63% match

Springer - Advances in Biology and Treatment of Glioblastoma

Springer

£109.96 10 Mar 2026
Central Nervous System Tumors - Primary and Secondary
63% match

Central Nervous System Tumors - Primary and Secondary

IntechOpen

£114.00 07 Feb 2026
GLIOBLASTOMA: Risk Factors, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatment)
63% match

GLIOBLASTOMA: Risk Factors, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatment)

£90.99 07 Mar 2026
Combined Modality Therapy of Central Nervous System Tumors (Medical Radiology)
63% match

Combined Modality Therapy of Central Nervous System Tumors (Medical Radiology)

Springer

£127.75 28 Apr 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
63% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

Springer

£76.81 05 Mar 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
63% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

£67.04 12 Jan 2026
New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics
63% match

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics

£117.69 13 Jan 2026
Springer - Oncology of CNS Tumors Medical Reference Book
63% match

Springer - Oncology of CNS Tumors Medical Reference Book

Springer

£120.00 28 Apr 2026
Pediatric CNS Tumors (Pediatric Oncology)
63% match

Pediatric CNS Tumors (Pediatric Oncology)

Springer

£128.11 10 Mar 2026
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
63% match

Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)

Humana

£5.29 17 Feb 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
63% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£141.86 16 Apr 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
63% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£61.16 08 Mar 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
63% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£87.30 07 Mar 2026
Glioblastoma
63% match

Glioblastoma

Elsevier

£75.29 08 Jan 2026
Glioblastoma
63% match

Glioblastoma

MDPI AG

£95.47 07 Mar 2026
Springer Tumors of the Central Nervous System, Volume 9
63% match

Springer Tumors of the Central Nervous System, Volume 9

Springer

£114.89 25 Apr 2026
Evidence based practice in Neuro-oncology
63% match

Evidence based practice in Neuro-oncology

Springer

£81.90 27 Feb 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
62% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£142.76 01 Apr 2026
In-silico-Modellierung der Progression und Radiotherapie maligner Hirntumoren
62% match

In-silico-Modellierung der Progression und Radiotherapie maligner Hirntumoren

£84.00 06 May 2026
New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)
62% match

New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)

Academic Press

£110.99 01 Mar 2026
Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)
62% match

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)

Elsevier

£85.79 10 Apr 2026
Gliomas: 171 (Recent Results in Cancer Research, 171)
62% match

Gliomas: 171 (Recent Results in Cancer Research, 171)

Springer

£82.86 23 Apr 2026